HB Wealth Management
VVOS icon

HB Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

HB Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.48K Buy
+10,000
New +$3K ﹤0.01% 1884

Other funds holding VVOS

Centurion Wealth Management
Centurion Wealth Management Mclean, Virginia $415M AUM 17.23% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Acorn Wealth Advisors
Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

HB Wealth Management's VVOS Position: Q3 2026 in Review

HB Wealth Management opened a new position in Vivos Therapeutics (VVOS) in Q3 2026: 10,000 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #1884 among its holdings.

6 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • HB Wealth Management held 10,000 shares of Vivos Therapeutics worth $1.48K as of Q3 2026.
  • Vivos Therapeutics was a new HB Wealth Management position in Q3 2026.
  • Vivos Therapeutics made up ﹤0.01% of HB Wealth Management's portfolio in Q3 2026, its #1884 holding.
  • 6 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on HB Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.